Merck to cut 1,200 sales jobs

Share this article:
Merck announced plans to cut 1,200 sales jobs in the US. The layoffs follow an FDA rejection of Cordaptive, a cholesterol drug that was to be packaged with Zocor, and weak sales of Vytorin following the ENHANCE controversy.
Share this article:

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.